These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
761 related articles for article (PubMed ID: 26979870)
21. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770 [TBL] [Abstract][Full Text] [Related]
22. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines. Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329 [TBL] [Abstract][Full Text] [Related]
23. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
24. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
25. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119 [TBL] [Abstract][Full Text] [Related]
26. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Niu XY; Peng ZL; Duan WQ; Wang H; Wang P Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755 [TBL] [Abstract][Full Text] [Related]
29. Silencing E6/E7 Oncoproteins in SiHa Cells Treated with siRNAs and Oroxylum indicum Extracts Induced Apoptosis by Upregulating p53/pRb Pathways. Sisin NNT; Kong AR; Edinur HA; Jamil NIN; Che Mat NF Appl Biochem Biotechnol; 2024 Jul; 196(7):4234-4255. PubMed ID: 37922032 [TBL] [Abstract][Full Text] [Related]
30. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
31. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer. Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Yoshinouchi M; Yamada T; Kizaki M; Fen J; Koseki T; Ikeda Y; Nishihara T; Yamato K Mol Ther; 2003 Nov; 8(5):762-8. PubMed ID: 14599809 [TBL] [Abstract][Full Text] [Related]
33. siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo. Khairuddin N; Gantier MP; Blake SJ; Wu SY; Behlke MA; Williams BR; McMillan NA Immunol Cell Biol; 2012 Feb; 90(2):187-96. PubMed ID: 21423261 [TBL] [Abstract][Full Text] [Related]
34. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
35. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells. Kim MS; Bak Y; Park YS; Lee DH; Kim JH; Kang JW; Song HH; Oh SR; Yoon DY Cell Biol Toxicol; 2013 Aug; 29(4):259-72. PubMed ID: 23955116 [TBL] [Abstract][Full Text] [Related]
36. [Development of new therapies targeting human papillomavirus molecules]. Kawana K Uirusu; 2014; 64(1):35-42. PubMed ID: 25765978 [TBL] [Abstract][Full Text] [Related]
37. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Bai L; Wei L; Wang J; Li X; He P Int J Gynecol Cancer; 2006; 16(2):718-29. PubMed ID: 16681752 [TBL] [Abstract][Full Text] [Related]
38. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions. Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398 [TBL] [Abstract][Full Text] [Related]
39. Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization. Palanichamy JK; Mehndiratta M; Bhagat M; Ramalingam P; Das B; Das P; Sinha S; Chattopadhyay P Mol Cancer Ther; 2010 Jul; 9(7):2114-22. PubMed ID: 20587668 [TBL] [Abstract][Full Text] [Related]
40. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M; Milner J Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]